Mac Bohanan
Neurology · Tallahassee, FLNPI 1861017139
Payments from drug & device makers
Across 67 payments — averaging $24.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$505
- Livanova USA, Inc.$172
- Teva Pharmaceuticals USA, Inc.$108
- Amgen$81
- Pfizer$79
- Greenwich Biosciences, Inc.$74
- plus $602 from 17 others
What the payments were for
- Food & beverage$1,53595%
- Education$875%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 20 | $505 |
| Livanova USA, Inc. | 5 | $172 |
| Teva Pharmaceuticals USA, Inc. | 2 | $108 |
| Amgen | 3 | $81 |
| Pfizer | 4 | $79 |
| Greenwich Biosciences, Inc. | 4 | $74 |
| SK Life Science, Inc. | 3 | $72 |
| Ipsen Biopharmaceuticals, Inc | 3 | $58 |
| Nevro Corp. | 2 | $55 |
| Jazz Pharmaceuticals Inc. | 3 | $54 |
| Novartis | 2 | $53 |
| AbbVie | 3 | $45 |
| Sanofi | 2 | $35 |
| AstraZeneca(2 entities) | 2 | $31 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $30 |
| EMD Serono, Inc. | 1 | $29 |
| Axsome Therapeutics, Inc. | 1 | $29 |
| Hospira, Inc. | 1 | $23 |
| Neurelis, Inc. | 1 | $21 |
| Kedrion Biopharma, Inc. | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| NS Pharma, Inc. | 1 | $15 |
| Novocure Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Sentiva$105
How this compares
$1,622 in reported general payments places this provider in the 40th percentile of 1,434 neurology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 15 | $402 |
Paid to pharmacies, not to this prescriber.
Other neurology in Tallahassee
- Ricardo AyalaTallahassee$6.7M
- Mark GoldsteinAtlantis$36.1M
- Derrick RobertsonTampa$27.6M
- Beth SafirsteinHallandale Beach$25.7M
- Michael PfefferMiami$24.5M
- Mark BrodyDelray Beach$20.5M
- Paayal PatelWest Palm Beach$17.3M
- Wendy BondFort Myers$14.7M
- William HoneycuttMaitland$14.1M
- Julie SchwartzbardAventura$13.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.